Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

AMATO, Marco Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.419
EU - Europa 3.514
AS - Asia 1.450
AF - Africa 61
SA - Sud America 16
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.469
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.411
IT - Italia 927
CN - Cina 870
FI - Finlandia 806
UA - Ucraina 523
SG - Singapore 397
IE - Irlanda 329
DE - Germania 306
GB - Regno Unito 163
SE - Svezia 103
RU - Federazione Russa 86
FR - Francia 75
CI - Costa d'Avorio 55
RO - Romania 55
BE - Belgio 54
TR - Turchia 46
IN - India 43
KR - Corea 35
NL - Olanda 15
CZ - Repubblica Ceca 14
CH - Svizzera 12
IR - Iran 12
PL - Polonia 11
GR - Grecia 10
BR - Brasile 9
CA - Canada 7
HK - Hong Kong 7
TW - Taiwan 7
UZ - Uzbekistan 7
AT - Austria 6
LB - Libano 6
ES - Italia 5
JP - Giappone 5
EG - Egitto 4
EU - Europa 4
PE - Perù 4
AU - Australia 3
BG - Bulgaria 3
CL - Cile 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
ID - Indonesia 2
IQ - Iraq 2
MK - Macedonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TZ - Tanzania 2
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DK - Danimarca 1
IL - Israele 1
KH - Cambogia 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 12.469
Salva come PNG Salva come JPEG
Città #
Fairfield 923
Ashburn 625
Chandler 605
Woodbridge 485
Wilmington 479
Ann Arbor 458
Houston 419
Seattle 372
Jacksonville 334
Dublin 329
Singapore 327
Cambridge 317
Medford 212
Palermo 188
Des Moines 160
Nanjing 159
Princeton 136
Boardman 109
Dearborn 94
Tulsa 84
Altamura 82
New York 72
Shenyang 69
Jinan 66
San Diego 65
Beijing 60
Changsha 56
Nanchang 56
Abidjan 55
Brussels 54
Lawrence 53
Tianjin 51
Izmir 44
Hebei 41
Milan 37
Ningbo 36
Zhengzhou 36
Jiaxing 31
Santa Clara 31
Munich 29
Phoenix 28
Kumar 27
Auburn Hills 26
Frankfurt 26
Guangzhou 26
Falls Church 25
London 24
Saint Petersburg 23
Taizhou 23
Verona 22
Hangzhou 21
Seongnam 21
Venice 20
Taiyuan 18
Atlanta 17
Helsinki 17
Los Angeles 16
Bucheon-si 14
San Paolo di Civitate 14
Lanzhou 13
Brno 12
Haikou 12
Norwalk 10
Orange 10
Redwood City 10
Rome 10
Chicago 9
Durham 9
Düsseldorf 9
Kunming 9
Ludwigshafen am Rhein 9
Moscow 8
Tehran 8
Taipei 7
Washington 7
Columbus 6
Fuzhou 6
Montegrotto Terme 6
Bremen 5
Hefei 5
Napoli 5
Pune 5
São Luís 5
Alicante 4
Bari 4
Den Haag 4
Edinburgh 4
Kilburn 4
Lima 4
Monreale 4
Sestri Levante 4
Albany 3
Catania 3
Central 3
Erice 3
Groningen 3
Padova 3
Pellezzano 3
Sofia 3
Stockholm 3
Totale 8.501
Salva come PNG Salva come JPEG
Nome #
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory 220
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. 195
Anaplastic Thyroid Carcinoma: A ceRNA Analysis Pointed to a Crosstalk between SOX2, TP53, and microRNA Biogenesis. 181
BRAFV600E mutation, TIMP-1 up-regulation and NF-{kappa}B activation: closing the loop on the papillary thyroid cancer trilogy. 179
In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines 178
The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome 177
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 176
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 174
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency 167
Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes 164
Fine-Needle Aspiration (FNAB) Molecular Analysis for the Diagnosis of Papillary Thyroid Carcinoma through BRAFv600E mutation and RET/PTC rearrangement 162
Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: the potential role of miR-155 as a biomarker for monitoring the estroprogestinic treatment 161
Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study 160
Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index 160
OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes. 159
Use of Glargine in Pregnant Women with Type 1 Diabetes Mellitus: A Case-Control Study 158
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 156
Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients. 155
Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. 154
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 153
Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein. 150
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. 150
Development of a fuzzy expert system for the control of glycemia in type 1 diabetic patients 148
The Metabolic Profile in Active Acromegaly is Gender-Specific. 147
Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy 141
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction 138
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. 136
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity. 136
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. 132
Correlation between Severity of Growth Hormone Deficiency and Thyroid Metabolism and Effects of Long-Term Growth Hormone Treatment on Thyroid Function in Children with Idiopathic Growth Hormone Deficiency. 131
Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes 126
Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. 125
Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome 124
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. 123
Il c-peptide come marker principale nella storia naturale del Diabete tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze 122
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment. 121
Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA). 120
Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: Results of a two-step cluster analysis 118
Cornea in acromegalic patients as a possible target of growth hormone action. 115
Clinical indications and proper use of Visceral Adiposity Index. 113
Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency. 112
Clamp euglicemico iperinsulinemico e test al glucagone come utili strumenti di valutazione degli effetti metabolici della terapia sostitutiva con GH. 111
Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations 110
Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment 108
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. 107
null 104
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. 102
Valutazione dell'insulinoresistenza tramite un test pasto standard 101
Espressione dei fattori di trascrizione di staminalità in cellule stromali (HASC) ottenute da tessuto adiposo viscerale e sottocutaneo 97
Safety of glargine therapy during pregnancy in women with type 1 diabetes mellitus. 96
Off-line control of the postprandial glycemia in type 1 diabetes patients by a fuzzy logic decision support 96
Body composition assessment for the definition of cardiometabolic risk. 96
The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. 95
GH-suppression test in acromegaly: comparison between OGTT and chocolate test 94
Sviluppo di un sistema di supporto decisionale tipo Fuzzy per il controllo della glicemia post-prandiale nel diabete mellito tipo 1 94
THE CLINICAL ACTIVITY SCORE IN MANAGEMENT OF GRAVES’ OPHTHALMOPATHY: CORRELATION WITH ORBITAL MR IMAGING. 93
The current version of the visceral adiposity index is not suitable for application in pediatric populations: comments on the article by Al-Daghri et al. 92
Rotterdam consensus, NIH and EAS: comparison among the three different diagnostic criteria for the diagnosis of PCOS. 91
Endocrine and pro-inflammatory activity of visceral (VAT) and subcutaneous (SAT) adipose tissue in morbidly obese patients with and without metabolic syndrome. 91
Changes in lipid profile and adipokine levels in GH deficient children during GH replacement therapy. 90
No effect of GH/IGF-1 excess on adrenal glands in acromegalic patients 89
Leptina e adiponectina nella valutazione del compenso glicometabolico in corso di diabete mellito di tipo 1 normopeso. 89
Visceral Adiposity Index (VAI): A Reliable Indicator Of Visceral Fat Function Associated With Cardiometabolic Risk. 88
null 87
Adrenal incidentaloma: a new contributing factor in metabolic syndrome 86
Variabili cliniche nella casistica del policlinico di Palermo nell’ambito del registro dei tumori della tiroide in Sicilia: Età, sesso, autoimmunità, tipo, dimensionilesionali e coinvolgimento delle stazioni linfonodali della tiroide 85
Insulin resistance and polycystic ovary syndrome. 85
L’uso del hrTSH nel follow up del microcarcinoma tiroideo in pazienti sottoposti a tiroidectomia totale 85
Visceral Adiposity Index (VAI) as a simple indicator of “adipose tissue dysfunction” in patients with type 2 diabetes. 85
BRAFV600E mutation and timp-1 hyper-expression in classical variants of papillary thyroid carcinoma (PTC). 83
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni contro regolatori. 82
Neck liymph nodes in chronic autoimmune thyroiditis: the sonographic pattern. 82
HYPERINSULINISM AND POLYCYSTIC OVARY SYNDROME (PCOS): ROLE OF INSULIN CLEARANCE. 82
Detection of BRAFv600E mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens. 81
Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia. 81
Effetti della terapia combinata (OHA+Insulina) su una casistica ambulatoriale di pazienti affetti da NIDDM. 81
BRAFV660E mutation and Timp-1 hyper-expression in classical variants of papyllary thyroid carcinoma. 79
Effetti di una terapia con glucocorticoidi ev ad alte dosi sull'oftalmopatia di Graves moderata-severa:uno studio caso-controllo 79
Variazioni plasmatiche del fattore di crescita insulino-simile (IGF-1) durante iperinsulinizzazione esogena (calmp euglicemico) in pazienti affetti da sindrome metabolica con e senza complicanze macrovascolari. 78
The adipose visceral dysfunction plays an important role in diabetes in Cushing disease. 78
Alterazioni del metabolismo glucidico determinate da eccesso di ormoni controregolatori: ruolo del GH 75
Use of antiepileptic drugs in women with polycystic ovary syndrome 74
The use of rh-TSH in the follow-up of thyroid microcarcinoma after total thyroidectomy 74
Visceral Adipose function, insulin sensitivity and secretion in active acromegaly. 73
Complete biochemical control and oituitary adenoma disappearance in a child with gigantism: efficay of octreotide therapy 72
AlKam Metabolic Syndrome Study (AlkaMeSy Study): Studio di prevalenza sulla sindrome metabolica. 72
Oligomenorrhea in PCOS is characterized by a high visceral adiposity index (VAI): a likely condition of cardiometabolic risk. 70
Prevalenza del cancro del colon e di altre neoplasie in una casistica ambulatoriale di soggetti affetti da diabete mellito tipo 2. 70
Adrenal incidentaloma: a new contributing factor in metabolic syndrome? 70
Polycistic ovary syndrome and antiepileptic drugs: a cross-sectional study 69
Low hrTSH-Tg levels in patients affected by papillary thyroid microcarcinoma are influenced by pre-surgery L-thyroxine therapy. 69
Marcatori di rischio diabetologico nella Sindrome dell’ovaio policistico (PCOS). 69
Utilizzo del Visceral Adiposity Index per l’identificazione di donne con sindrome iperandrogenica a rischio cardiometabolico. 67
Low Estradiol-to-Testosterone ratio is associated with low progesterone levels and atherogenic lipidic pattern in women with policystic ovary syndrome (PCOS). 67
Detection of BRAFV600 mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specimens 66
Alte dosi di cabergolina migliorano i parametri metabolici in pazienti affetti da prolattinoma. 66
Il c-peptide come marker principale nella storia naturale del Diabete di tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze. 65
The relationship between metabolic syndrome and bone health: results of a retrospective gender specific female study. 65
Utilizzo dell’insulina detemir in una casistica di donne affette da diabete tipo 1 in gravidanza: uno studio caso-controllo retrospettivo. 64
Use of basal insulin analog detemir in pregnant women with type 1 diabetes: a case-control retrospective study 64
Totale 11.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.150
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.696 0 0 0 0 0 358 260 190 290 147 379 72
2020/20211.410 71 139 91 140 96 26 163 72 234 63 152 163
2021/20221.492 42 325 35 48 87 63 64 67 151 197 109 304
2022/20231.854 234 265 35 179 233 304 133 130 224 15 77 25
2023/2024707 42 155 45 53 44 173 40 57 3 8 10 77
2024/2025683 76 102 154 216 67 68 0 0 0 0 0 0
Totale 13.036